[Federal Register Volume 62, Number 92 (Tuesday, May 13, 1997)]
[Notices]
[Page 26319]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-12457]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Chronic Fatigue Syndrome Coordinating Committee: Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting:
Name: Chronic Fatigue Syndrome Coordinating Committee (CFSCC).
Time and Date: 10 a.m.-12 noon, 1:30-5 p.m., May 29, 1997.
Place: Room 503A, Hubert H. Humphrey Building, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
The meeting room will accommodate 85 people.
Purpose: The Committee is charged with providing advice to the
Secretary, the Assistant Secretary for Health, and the Commissioner,
Social Security Administration (SSA) to assure interagency
coordination and communication regarding chronic fatigue syndrome
(CFS) research and other related issues; facilitating increased
Department of Health and Human Services (HHS) and agency awareness
of CFS research and educational needs; developing complementary
research programs that minimize overlap; identifying opportunities
for collaborative and/or coordinated efforts in research and
education; and developing informed responses to constituency groups
regarding HHS and SSA efforts and progress.
Matters to be Discussed: Agenda items will include defining the
scope and mission of the Chronic Fatigue Syndrome Coordinating
Committee; review of an approach to the current disease name;
prioritization of education of the physician/provider population;
disability issues; therapeutic agents and their assessment;
measurement of functional activity; and pediatric CFS.
Agenda items are subject to change as priorities dictate.
Public comments will be received at the meeting for
approximately 90 minutes. Persons wishing to make oral comments
should notify the Executive Secretary, Lisa Blake-DiSpigna, by fax
(404/639-4138) or by telephone (404/639-3227) no later than the
close of business on May 23, 1997. All requests to make oral
comments should contain the name, address, telephone number, and
organizational affiliation of the presenter. These comments will
become a part of the official record of the meeting. Due to the time
available, public comments will be limited to five minutes per
person.
Notice: In the interest of security, the Department has
instituted stringent procedures for entrance to the Hubert H.
Humphrey Building by non-government employees. Thus, persons without
a government identification card will need to provide a photo ID and
know the subject and room number of the meeting in order to be
admitted into the building. Visitors must use the Independence
Avenue entrance.
Contact Person for More Information: Renee Ross, Division of
Viral and Rickettsial Diseases, National Center for Infectious
Diseases, CDC, 1600 Clifton Road, NE, MS A30, Atlanta, Georgia
30333, telephone 404/639-3574.
Dated: May 7, 1997.
Nancy C. Hirsch,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention (CDC).
[FR Doc. 97-12457 Filed 5-12-97; 8:45 am]
BILLING CODE 4163-18-P
